THEMIS Top Line: Ticagrelor Cuts Event Risk in Diabetics With CAD THEMIS Top Line: Ticagrelor Cuts Event Risk in Diabetics With CAD

Adding daily ticagrelor (Brilinta/Brilique) to aspirin conferred a significant benefit in the trial with more than 19,000 high-risk diabetics in top-line results announced by AstraZeneca.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news